USPTO serial 79141824
MOLECUTECH
Reviewed by CopyMark Law Group
Reg. 4650967Status 404
- Filing date
- Status date
- Registration date
- Dec 9, 2014
- Examiner
- VAGHANI, MAYUR C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MOLECUTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gyeonggi-do 449-834, KR
Gyeonggi-do 449-834, KR
Gyeonggi-do 449-834, KR
Gyeonggi-do 449-834, KR
Gyeonggi-do 449-834, KR
Gyeonggi-do 449-834, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yoon S. Ham
YOON S. HAM LOWE HAUPTMAN & HAM, LLPSTE 14002318 MILL RDALEXANDRIA, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Molecular diagnostic preparations for medical purposes for detecting mycobacterium tuberculosis (MTB) by real-time PCR amplification; molecular diagnostic preparations for medical purposes for simultaneously detecting mycobacterium tuberculosis (MTB) and nontuberculous mycobacteria (NTM) by real-time PCR amplification; molecular diagnostic preparations for medical purposes for identifying mycobacterium tuberculosis(MTB) and a total of 19 kinds of nontuberculous mycobacteria(NTM) and detecting about 100 kinds of nontuberculous mycobacteria(NTM) by analyzing PCR amplification products using a reverse blot hybridization assay (REBA); molecular diagnostic preparations for medical purposes for simultaneously detecting rifampin and isoniazid susceptibilities by analyzing PCR amplification products using a reverse blot hybridization assay (REBA); molecular diagnostic preparations for medical purposes for detecting resistance to fluoroquinolone, kanamycin and streptomycin, which are second-line drugs, by analyzing PCR amplification products using a reverse blot hybridization assay (REBA); molecular diagnostic preparations for medical purposes for simultaneously detecting human paplilloma virus (HPV), the major cause of uterine cervical cancer and a total of 25 kinds of HPV by analyzing PCR amplification products using a reverse blot hybridization assay (REBA); molecular diagnostic preparations for medical purposes for analyzing the rpoB gene region, which shows species-specific diversity, by PCR-restriction fragment length polymorphism analysis (PCR-RFLP-PRA); molecular diagnostic preparations for medical purposes for simultaneously detecting mycobacterium tuberculosis (MTB) and nontuberculous mycobacteria (NTM) by PCR amplification of the RD (Region of Difference) gene region, which present specifically in mycobacterium tuberculosis (MTB), and the rpoB gene region which is present commonly in all mycobacteria, including MTB; molecular diagnostic preparations for medical purposes for detecting mycobacterium and body fluids, which contain a small number of bacteria | SECTION 71 - CANCELLED | — |
| 010 | A fully automatic system related to tuberculosis diagnosis, namely, cytometers for medical diagnostic use, diagnostic apparatus for the detection of tuberculosis; a medical system for real-time gene amplification, namely, synthetic media for use in the augmentation of genes for medical purposes, medical devices for obtaining body fluid samples containing genes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by YD Electronics Co., Ltd.
- Other trademarks owned by YD Electronics Co., Ltd.
- Other trademarks owned by YD Electronics Co., Ltd.
- Other trademarks owned by YD Diagnostics Co., Ltd.
- Other trademarks owned by YD Diagnostics Co., Ltd.
- Other trademarks owned by YD Diagnostics Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named MOLECUTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 25, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Feb 25, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 17, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 23, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jun 23, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 25, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 25, 2021 | C71T | CANCELLED SECTION 71 | — |
| May 22, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 1, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 1, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 9, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 9, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 23, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 3, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 19, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 18, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 18, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 7, 2014 | ALIE | ASSIGNED TO LIE | — |
| Aug 5, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 4, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 1, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 7, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 7, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 7, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 6, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 31, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 31, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 30, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |